[80] demonstrated that AKT can regulate TFEB activity by blocking its nuclear translocation in a Batten disease mouse model and that AKT inhibition attenuated neuropathology observed in the model. The gene discussed is AKT1; the disease is juvenile neuronal ceroid lipofuscinosis.